Timber Pharmaceuticals, Inc.
TMBR
TMBR was delisted on the 28th of November, 2023.
21 hedge funds and large institutions have $7.83M invested in Timber Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 3 closing their positions.
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
93% more capital invested
Capital invested by funds: $4.06M → $7.83M (+$3.77M)
40% more funds holding
Funds holding: 15 → 21 (+6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$703K |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
+$460K |
| 3 |
VF
Virtu Financial
New York
|
+$83K |
| 4 |
Barclays
London,
United Kingdom
|
+$71.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$68.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$740K |
| 2 |
AC
Armistice Capital
New York
|
-$382K |
| 3 |
Millennium Management
New York
|
-$59K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Millennium Management
New York
| – | -$59K | -36 | Closed |
|
TMBR Hedge Fund Activity: Q1 2018 in Review
21 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q1 2018, worth a combined $7.83M — up 93% from $4.06M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new TMBR positions and 3 closed out — a net gain of 6 holders — while 6 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, adding an estimated $703K. The largest seller was Sabby Management, exiting entirely with an estimated $740K sold.
- 21 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q1 2018, up from 15 in Q4 2017.
- Funds reported $7.83M of Timber Pharmaceuticals, Inc. stock for Q1 2018, up 93% quarter-over-quarter.
- 9 funds opened new Timber Pharmaceuticals, Inc. positions in Q1 2018 and 3 closed out, a net change of +6 holders.
- The largest Timber Pharmaceuticals, Inc. buyer in Q1 2018 was Vanguard Group, an estimated $703K added.
- The largest Timber Pharmaceuticals, Inc. seller in Q1 2018 was Sabby Management, an estimated $740K sold.
Based on aggregated 13F filings for Q1 2018.